Track topics on Twitter Track topics that are important to you
The New Zealand Commerce Commission has issued warnings to GlaxoSmithKline and AFT Pharmaceuticals for marketing products which contain the same active ingredients for different indications.
Original Article: Double trouble: NZ issues warnings to GSK & AFT for ‘twin’ productsNEXT ARTICLE
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...